Pfizer raises vaccine sales forecast to $33.5 bln

Pfizer on Wednesday raised its forecast for sales of the COVID-19 vaccine that it developed with Germany's BioNTech by 28.8% to $33.5 billion, as countries scramble to secure supply of the shots. Fred Katayama reports.